temozolomide

temozolomide
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2015-11-25 00:00:00
Sponsor AmpliPharm Pharmaceuticals, LLC;970 Peachtree Industrial Boulevard, Suite 100;Suwanee, Georgia, 30024
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM